eli lilly compound tirzepatide hits out against the use of Mounjaro, Zepbound for 'cosmetic weight loss' Lilly finds bacteria, other impurities

Significant weight loss accumulates over months

the clinical significance in humans remains under investigation and is not yet established for retatrutide specifically [24] [25] Other class-associated cautions: Based on the broader GLP-1/GIP receptor agonist class, potential effects on gallbladder function and delayed gastric emptying are relevant considerations, though evidence specific to retatrutide is still emerging It is important to note that this evidence derives from early-phase trials conducted under controlled conditions with medical supervision

Reasonably priced, quick and easy ordering/delivery process

Vilsbll T, Zdravkovic M, Le-Thi T, et al

The most frequently reported side effects of tirzepatide are gastrointestinal in nature, occurring in a substantial proportion of patients during clinical trials

The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis, Addiction, 2024